An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access.
Saved in:
| Title: | An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. |
|---|---|
| Authors: | Jones AV; Gyroscope Therapeutics Limited, London, United Kingdom., Curtiss D; Gyroscope Therapeutics Limited, London, United Kingdom., Harris C; Gyroscope Therapeutics Limited, London, United Kingdom., Southerington T; Finnish Biobank Cooperative-FINBB, Turku, Finland.; University of Turku, Turku, Finland., Hautalahti M; Finnish Biobank Cooperative-FINBB, Turku, Finland., Wihuri P; Finnish Biobank Cooperative-FINBB, Turku, Finland., Mäkelä J; Finnish Biobank Cooperative-FINBB, Turku, Finland., Kallionpää RE; Auria Biobank, Turku University Hospital and University of Turku, Turku, Finland., Makkonen E; Finnish Clinical Biobank Tampere, Tampere, Finland., Knopp T; Helsinki Biobank, HUS, Helsinki University Hospital, Helsinki, Finland., Mannermaa A; Biobank of Eastern Finland, KYS, Kuopio, Finland., Mäkinen E; Biobank of Central Finland, Hospital Nova of Central Finland, Jyväskylä, Finland., Moilanen AM; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland., Tezel TH; Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, United States of America., Waheed NK; Gyroscope Therapeutics Limited, London, United Kingdom.; Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States of America. |
| Corporate Authors: | SCOPE Study group |
| Source: | PloS one [PLoS One] 2022 Sep 06; Vol. 17 (9), pp. e0272260. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36067162 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jones+AV%22">Jones AV</searchLink>; Gyroscope Therapeutics Limited, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Curtiss+D%22">Curtiss D</searchLink>; Gyroscope Therapeutics Limited, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harris+C%22">Harris C</searchLink>; Gyroscope Therapeutics Limited, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Southerington+T%22">Southerington T</searchLink>; Finnish Biobank Cooperative-FINBB, Turku, Finland.; University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Hautalahti+M%22">Hautalahti M</searchLink>; Finnish Biobank Cooperative-FINBB, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Wihuri+P%22">Wihuri P</searchLink>; Finnish Biobank Cooperative-FINBB, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Mäkelä+J%22">Mäkelä J</searchLink>; Finnish Biobank Cooperative-FINBB, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Kallionpää+RE%22">Kallionpää RE</searchLink>; Auria Biobank, Turku University Hospital and University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Makkonen+E%22">Makkonen E</searchLink>; Finnish Clinical Biobank Tampere, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Knopp+T%22">Knopp T</searchLink>; Helsinki Biobank, HUS, Helsinki University Hospital, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Mannermaa+A%22">Mannermaa A</searchLink>; Biobank of Eastern Finland, KYS, Kuopio, Finland.<br /><searchLink fieldCode="AU" term="%22Mäkinen+E%22">Mäkinen E</searchLink>; Biobank of Central Finland, Hospital Nova of Central Finland, Jyväskylä, Finland.<br /><searchLink fieldCode="AU" term="%22Moilanen+AM%22">Moilanen AM</searchLink>; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland.<br /><searchLink fieldCode="AU" term="%22Tezel+TH%22">Tezel TH</searchLink>; Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, United States of America.<br /><searchLink fieldCode="AU" term="%22Waheed+NK%22">Waheed NK</searchLink>; Gyroscope Therapeutics Limited, London, United Kingdom.; Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States of America. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22SCOPE+Study+group%22">SCOPE Study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2022 Sep 06; Vol. 17 (9), pp. e0272260. <i>Date of Electronic Publication: </i>2022 Sep 06 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36067162 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0272260 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0272260 Titles: – TitleFull: An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jones AV – PersonEntity: Name: NameFull: Curtiss D – PersonEntity: Name: NameFull: Harris C – PersonEntity: Name: NameFull: Southerington T – PersonEntity: Name: NameFull: Hautalahti M – PersonEntity: Name: NameFull: Wihuri P – PersonEntity: Name: NameFull: Mäkelä J – PersonEntity: Name: NameFull: Kallionpää RE – PersonEntity: Name: NameFull: Makkonen E – PersonEntity: Name: NameFull: Knopp T – PersonEntity: Name: NameFull: Mannermaa A – PersonEntity: Name: NameFull: Mäkinen E – PersonEntity: Name: NameFull: Moilanen AM – PersonEntity: Name: NameFull: Tezel TH – PersonEntity: Name: NameFull: Waheed NK IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 09 Text: 2022 Sep 06 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 17 – Type: issue Value: 9 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |